InMode (INMD) Competitors

InMode (NASDAQ:INMD) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability, community ranking and valuation.

Does the media refer more to INMD or TMDX?

In the previous week, InMode had 3 more articles in the media than TransMedics Group. MarketBeat recorded 11 mentions for InMode and 8 mentions for TransMedics Group. InMode's average media sentiment score of 1.63 beat TransMedics Group's score of 1.02 indicating that InMode is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	9 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
TransMedics Group	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate INMD or TMDX?

InMode currently has a consensus price target of $18.54, indicating a potential upside of 25.62%. TransMedics Group has a consensus price target of $126.70, indicating a potential upside of 1.60%. Given InMode's higher possible upside, equities research analysts clearly believe InMode is more favorable than TransMedics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13
TransMedics Group	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.82

Does the MarketBeat Community prefer INMD or TMDX?

InMode received 48 more outperform votes than TransMedics Group when rated by MarketBeat users. Likewise, 71.18% of users gave InMode an outperform vote while only 59.28% of users gave TransMedics Group an outperform vote.

Company	Underperform	Outperform
InMode	Outperform Votes 163 71.18%	Underperform Votes 66 28.82%
TransMedics Group	Outperform Votes 115 59.28%	Underperform Votes 79 40.72%

Which has higher earnings & valuation, INMD or TMDX?

InMode has higher earnings, but lower revenue than TransMedics Group. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$392.41M	2.62	$181.27M	$2.33	6.33
TransMedics Group	$488.23M	8.64	-$25.03M	$1.36	91.70

Is INMD or TMDX more profitable?

InMode has a net margin of 45.91% compared to TransMedics Group's net margin of 8.14%. TransMedics Group's return on equity of 18.74% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	45.91%	18.25%	16.33%
TransMedics Group	8.14%	18.74%	4.39%

Which has more risk and volatility, INMD or TMDX?

InMode has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in INMD or TMDX?

68.0% of InMode shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

InMode beats TransMedics Group on 10 of the 19 factors compared between the two stocks.